Ardelyx Inc. (NASDAQ:ARDX)’s traded shares stood at 0.77 million during the latest session, with the company’s beta value hitting 1.04. At the last check today, the stock’s price was $4.00, to imply an increase of 0.25% or $0.01 in intraday trading. The ARDX share’s 52-week high remains $4.16, putting it -4.0% down since that peak but still an impressive 87.75% since price per share fell to its 52-week low of $0.49. The company has a valuation of $884.06M, with an average of 13.29 million shares in intraday trading volume over the past 10 days and average of 8.00 million shares over the past 3 months.

Analysts have given a consensus recommendation of a Buy for Ardelyx Inc. (ARDX), translating to a mean rating of 1.50. Of 7 analyst(s) looking at the stock, 0 analyst(s) give ARDX a Sell rating. 0 of those analysts rate the stock as Overweight while 1 advise Hold as 6 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at -$0.1.

Ardelyx Inc. (NASDAQ:ARDX) trade information

After registering a 0.25% upside in the latest session, Ardelyx Inc. (ARDX) has traded red over the past five days. The stock hit a weekly high of 4.01 this Wednesday, 03/15/23, jumping 0.25% in its intraday price action. The 5-day price performance for the stock is 4.71%, and 30.29% over 30 days. With these gigs, the year-to-date price performance is 40.35%. Short interest in Ardelyx Inc. (NASDAQ:ARDX) saw shorts transact 10.99 million shares and set a 2.38 days time to cover.

Ardelyx Inc. (ARDX) estimates and forecasts

Looking at statistics comparing Ardelyx Inc. share performance against respective industry, we note that the company has outperformed competitors. Ardelyx Inc. (ARDX) shares are 177.77% up over the last 6 months, with its year-to-date growth rate higher than industry average at 35.71% against 9.50%. Revenue is forecast to grow 52.40% this quarter before jumping 52.60% for the next one. The rating firms project that company’s revenue will grow 45.90% compared to the previous financial year.

Revenue forecast for the current quarter as set by 5 analysts is $10.61 million. Meanwhile, for the quarter ending Jun 2023, a total of 5 analyst(s) estimate revenue growth to $13.61 million.Earnings reports from the last fiscal year show that sales brought in $468k and $2.53 million respectively in the corresponding quarters. In this case, analysts estimate current quarter sales to rise 2,167.10% before jumping 438.80% in the following quarter.

An assessment of the company’s 5-year growth patterns shows that annual earnings grew an estimated 20.80% for the past 5-year period. While 2023 is set for a 72.10% return in earnings, projections for the next 5 years are at 30.00% annually.

ARDX Dividends

Ardelyx Inc. has its next earnings report out between May 03 and May 08. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too. Ardelyx Inc. has a forward dividend ratio of 0, with the share yield ticking at 0.00% to continue the rising pattern observed over the past year. The company’s average dividend yield trailing the past 5-year period is 0.00%.

Ardelyx Inc. (NASDAQ:ARDX)’s Major holders

Ardelyx Inc. insiders hold 1.50% of total outstanding shares, with institutional holders owning 40.17% of the shares at 40.78% float percentage. In total, 40.17% institutions holds shares in the company, led by Janus Henderson Group PLC. As of Dec 30, 2022, the company held over 19.77 million shares (or 9.58% of shares), all amounting to roughly $79.2 million.

The next major institution holding the largest number of shares is Millennium Management Llc with 10.38 million shares, or about 5.03% of shares outstanding. As of the market price on Dec 30, 2022, these shares were worth $41.59 million.

We also have Vanguard Total Stock Market Index Fund and Janus Henderson Global Life Sciences Fund as the top two Mutual Funds with the largest holdings of the Ardelyx Inc. (ARDX) shares. Going by data provided on Sep 29, 2022, Vanguard Total Stock Market Index Fund holds roughly 3.89 million shares. This is just over 1.96% of the total shares, with a market valuation of $15.57 million. Data from the same date shows that the other fund manager holds a little less at 2.94 million, or 1.48% of the shares, all valued at about 11.78 million.